INH: Standing Between You and Tuberculosis
This pamphlet discusses the use of the drug isoniazid (INH) to treat latent TB infection. It provides information on the length of treatment and side effects.
Author:
Florida Department of Health, Florida Department of Health, Bureau of TB and Refugee Health
Audiences:
Non-U.S.-born persons, Persons With LTBI
Topic:
Treatment- Adverse Reactions, Treatment - Latent TB infection (Inactive TB), Treatment- Medication Information, Treatment- Patient Adherence
Country of Origin:
United States
Global resources for the prevention,
management, and elimination of TB.